Subacute Cutaneous Lupus Erythematosus
GPTKB entity
Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
autoimmune disease
cutaneous lupus erythematosus |
| gptkbp:affects |
gptkb:skin
|
| gptkbp:associatedWith |
gptkb:systemic_lupus_erythematosus
|
| gptkbp:canProgressTo |
gptkb:systemic_lupus_erythematosus
|
| gptkbp:commonIn |
gptkb:women
|
| gptkbp:diagnosedBy |
skin biopsy
antinuclear antibody test anti-La/SSB antibody test anti-Ro/SSA antibody test |
| gptkbp:firstDescribed |
1979
|
| https://www.w3.org/2000/01/rdf-schema#label |
Subacute Cutaneous Lupus Erythematosus
|
| gptkbp:notableAntibody |
gptkb:anti-La/SSB
gptkb:anti-Ro/SSA |
| gptkbp:onset |
young to middle-aged adults
|
| gptkbp:prevalence |
rare
|
| gptkbp:riskFactor |
ultraviolet light exposure
genetic predisposition |
| gptkbp:symptom |
photosensitivity
annular lesions non-scarring rash papulosquamous lesions |
| gptkbp:treatment |
antimalarial drugs
sun protection topical corticosteroids |
| gptkbp:bfsParent |
gptkb:Lupus_Erythematosus
|
| gptkbp:bfsLayer |
7
|